STICHTING SUPPORT TROFOBLAST ZIEKTEN
ANBI publication information
General information
|
Name |
Stichting Support Trofoblast Ziekten |
|
RSIN / tax number |
866690128 |
|
Statutory seat |
Amersfoort, the Netherlands |
|
Established |
24 June 2024, by notarial deed executed before mr. Rafique Jabri, civil-law notary in Hilversum |
|
Contact details |
N.E. van Trommel |
Objective
The objective of the foundation is: to expand knowledge and expertise in the field of trophoblast diseases, in the broadest sense of the word.
The foundation also aims to perform all further actions that relate to the aforementioned objective in the broadest sense or that may be conducive thereto.
The foundation endeavors to achieve its objective through, among other things, education, research, and the sharing of knowledge and resources.
Outline of the policy plan
The foundation pursues its objective through education, research, and the sharing of knowledge and resources in the field of trophoblast diseases.In doing so, the following applies in particular:
• The board meets at least twice a year: within six months after the end of the financial year, the annual meeting is held, at which the balance sheet and the statement of income and expenses are adopted, and at least one further meeting is held each year.
• The board maintains a proper administration of the foundation's assets and activities and retains the books and records for seven years.
• The foundation's assets are formed through contributions, donations, subsidies, bequests, and proceeds from its own activities, and are applied exclusively to the foundation's objective.
For as long as the founder is the sole board member, she combines the functions of chair, secretary, and treasurer in one person, and is responsible both for the day-to-day management and for the policy decisions needed to further the foundation's objective.
The foundation was established on 24 June 2024. Its first financial year runs from incorporation through 31 December 2025. Concrete activities and financial results will be reported on after this first financial year has ended.
Board composition
• Mrs C.A.R. Lok, chair
• Mr M.J. Seckl, member
• Mr. F. Sweep, member
• Mrs. N.E. van Trommel –secretary, and treasurer
Remuneration policy
Board members receive no remuneration for their work. They are, however, entitled to reimbursement of costs reasonably incurred in the performance of their duties.
Report on activities carried out
To be published on this page after the end of the first financial year (through 31 December 2025).
Financial accountability
The balance sheet and the statement of income and expenses are adopted annually by the board within six months after the end of the financial year, and subsequently published on this page. For the first financial year (24 June 2024 through 31 December 2025), this will be no later than 30 June 2026.